Polygenic tests rolled out across UK private sector
Private health providers across the UK will offer a genome-wide genomic test to assess long-term health risks...
A cancer that forms in tissues of the breast. Breast cancers occur in both women and men, although male breast cancer is rare.
Private health providers across the UK will offer a genome-wide genomic test to assess long-term health risks...
The NHS is to roll out a world first DNA-based blood genetic test for breast and lung cancer patients across England...
by Nina O'Toole
A new combination treatment has yielded 100 percent survival for patients with 'aggressive' breast cancers, three years post-surgery...
Methylation in the placentas of male and female fetuses has marked differences, according to a study by researchers at the National Institutes of Health, Bethesda, Maryland...
An algorithm called PRRDetect has been developed to identify immunotherapy-susceptible cancers...
'Established in 2007, in a gale of publicity, 23andMe benefitted from the valetudinarian personal genetic healthcare imaginary that appeared in the wake of the Human Genome Project,' writes Dr Pete Mills, as he documents the rise and fall of 23andMe...
The British health insurance and healthcare company Bupa plans to offer an approach to people's genomic data that, it is claimed, can evaluate an individual's risk of developing seven common diseases...
Environmental factors could be more influential in health and premature death than our genes, according to a new study...
Dr Dan Jacobson concludes Lawrence Ingrassia's book is: 'an expansive, masterful piece of science communication, which doubles beautifully as memoir and biography of modern oncology'...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.